Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Nov;85(22):8751-5.
doi: 10.1073/pnas.85.22.8751.

Ex vivo model of an immobilized-enzyme reactor

Affiliations

Ex vivo model of an immobilized-enzyme reactor

H Bernstein et al. Proc Natl Acad Sci U S A. 1988 Nov.

Abstract

Immobilized-enzyme reactors are beginning to be studied for a variety of therapeutic applications. To facilitate the design of these devices for different clinical situations and a diverse patient population, mathematical models may be valuable. An immobilized-heparinase (EC 4.2.2.7) reactor was selected as a model system. The device removes heparin from blood that has been anticoagulated to prevent thrombus formation. Heparinase was immobilized to cross-linked agarose particles. A mathematical model was developed to describe the clearance of heparin by the reactor ex vivo and compared to experimental clearances measured in sheep. The model accounted for enzymatic degradation as well as the binding of heparin and its breakdown products to antithrombin. The device was modeled as a steady-state continuously stirred tank reactor. Molar conservation equations within the agarose particles accounted for simultaneous diffusion and chemical reaction. The model had no adjustable parameters and was able to predict the clearance of heparin within 5-25% for three different animals and 12 different perfusions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1965 Jan;94:84-90 - PubMed
    1. Kidney Int. 1987 Oct;32(4):452-63 - PubMed
    1. J Appl Physiol. 1973 Feb;34(2):181-7 - PubMed
    1. Semin Hematol. 1977 Oct;14(4):427-40 - PubMed
    1. Cancer Res. 1978 Jul;38(7):1936-41 - PubMed

Publication types